Jason Wittes
Recent Articles about Cardiol Therapeutics
Pharmaceutical Company Discovers Breakthrough Heart Treatment in Canada 08/11/2025
Top-line results from Cardiol Therapeutics' (CRDL:TSX; CRDL:NASDAQ) ARCHER study for Acute Myocarditis are quite promising, writes Roth Capital Partners Analyst Jason Wittes in an updated research note.
Canadian Pharmaceutical Company Discovers Breakthrough Cardiovascular Treatment 08/11/2025
Clinical-stage life sciences company Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) announces topline results from its Phase II clinical study involving patients with acute myocarditis. Read why analysts like this pharmaceutical stock.
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
